Sort
146,196 grants matching “diabetes”
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes
$993,807Dung "zung" Thai · Remd Biotherapeutics, Inc. · R44 · FY2020 · DK
Enabling clinical tissue microstructure imaging as a diagnostic tool in wide-bore 3T MRI
$993,663Thomas K Foo · Ge Medical Systems Information Technologies, Inc · U01 · FY2024 · EB
A MULTIDISCIPLINARY NMR CENTER FOR BIOMEDICAL RESEARCH
$993,640Chien Ho · Carnegie-Mellon University · P41 · FY2012 · EB
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$993,629Benjamin Michael Looney · Inspira Therapeutics, Inc. · R44 · FY2021 · DK
Midwest Developmental Center for AIDS Research (D-CFAR)
$993,578Elvin H. Geng · Washington University · P30 · FY2025 · AI
Identifying genetic modifiers of severity in ADPKD
$993,557Peter C. Harris · Mayo Clinic Rochester · R01 · FY2010 · DK
TrialNet: Diabetes Type 1 Prevention Trial
$993,520Peter A Gottlieb · University Of Colorado Denver · U01 · FY2007 · DK
Harnessing engineered T regulatory cells to promote beta cell health in T1D
$993,436Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · DK
Single-cell, multi-omic investigation of epicardial adipose and coronary endothelial dysfunction in type 1 diabetes
$993,436Amit Majithia · University Of California, San Diego · U01 · FY2025 · DK
An Intraperitoneal Insulin Delivery System for Management of Type 1 Diabetes
$993,339Christopher Hanson · Perikinetics Inc · R44 · FY2021 · DK
Assessment of Multiple Dose Administration of Glucagon Receptor Blocker REMD477 in Type 1 Diabetes
$993,326Dung "zung" Thai · Remd Biotherapeutics, Inc. · R44 · FY2019 · DK
Defining the genetic basis of human respiratory chain disease
$993,317Vamsi Krishna Mootha · Massachusetts General Hospital · RC2 · FY2009 · HG
Biomarkers of ABCA1 mediated functions in Alzheimers disease
$993,303Hussein N Yassine · University Of Southern California · R01 · FY2020 · AG
IDENTIFICATION OF NEW ACETYL-COA CARBOXYLASE INHIBITORS
$993,292Tedd D Elich · Cropsolution, Inc. · R44 · FY2007 · DK
Chronic Renal Insufficiency Cohort Study II
$993,189Alan S Go · Kaiser Foundation Research Institute · U01 · FY2008 · DK
Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 Diabetes
$993,178Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2021 · DK
Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies
$993,146Morgan Chandler · Mimetas Us, Inc. · R44 · FY2023 · DK
BODY COMPOSITION: METHODS, MODEL &CLINICAL APPLICATION
$993,053St. Luke'S-Roosevelt Inst For Hlth Scis · P01 · FY2005 · DK
Non-Clinical Pharmacology of CX-01
$992,960Galina Vid · Ceramedix Holding, Llc · R44 · FY2025 · AI
Clinical Evaluation of a Long Term Implanted Glucose Sensor
$992,943Joseph Y. Lucisano · Glysens, Inc. · R44 · FY2015 · DK
MIT Laser Biomedical Research Center (P41-RR02594)
$992,896Peter T. So · Massachusetts Institute Of Technology · P41 · FY2016 · EB
ENICTO Consortium Coordinating Center
$992,893Scott Evans · George Washington University · U24 · FY2022 · CA
Improving physical function and quality of life in older adults with prediabetes utilizing interactive small-group resistance training through video conference technology
$992,816Eric Levitan · Impactiv, Inc. · R44 · FY2023 · AG
Cardiovascular Health and Needs Assessment in Washington D.C.
$992,787Tiffany Powell · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
AUTOIMMUNITY CENTERS OF EXCELLENCE
$992,726Columbia University Health Sciences · U19 · FY2000 · AI